United States

Pfizer Inc (PFE)

PFE on New York Consolidated

21 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

More From Around the Web

Name Age Since Current Position

Ian Read

62 2011 Chairman of the Board, Chief Executive Officer

Frank D'Amelio

58 2010 Chief Financial Officer, Executive Vice President - Business Operations

Albert Bourla

53 2016 Group President - Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business

Mikael Dolsten

57 2010 President - Worldwide Research and Development

John Young

51 2014 Group President - Global Established Pharma Business